Oncology

Non-Small Cell Lung Cancer

Expert Perspectives in Non–Small Cell Lung Cancer to Cover Key Topics in Non–Small Cell Lung Cancer Treatment

expert perspectives by Bruce E. Johnson, MD; Gregory J. Riely, MD, PhD; Jeffrey Crawford, MD

Overview

Expert Perspectives delivers health care providers with insights from key thought leaders on the latest advancements and current practices in medicine, in a concise and timely format. This issue of Expert Perspectives in Non–Small Cell Lung Cancer will feature selected topics in Non–Small Cell Lung Cancer that we hope you will find of value in your clinical practice.

The clinicians who were surveyed selected the following experts and topics.

Community-Selected Experts:

Jeffrey Crawford, MD

George Barth Geller Professor for Research in Cancer Duke University Medical Center Lead PI of NCTN LAPS Grant Duke Cancer Institute Durham, NC

Bruce E. Johnson, MD

Institute Physician Dana-Farber Cancer Institute Professor of Medicine Harvard Medical School Boston, MA

Gregory J. Riely, MD, PhD

Vice Chair, Clinical Research Department of Medicine Memorial Sloan Kettering Cancer Center New York, NY

Community-Selected Topics:

Expert Roundtables

• Beyond EGFR and ALK: Targeted Therapies for Non–Small Cell Lung Cancer • Promising Research Directions: The Future of Non–Small Cell Lung Cancer Treatment • Unmet Needs and Opportunities in Advanced Non–Small Cell Lung Cancer • Combined Treatment Modalities for Older Patients With Advanced Non–Small Cell Lung Cancer

Clinical Topic Updates

• Biomarkers for Response to Immune Checkpoint Inhibition • Emerging Targets to Consider Including in a Larger Molecular Testing Panel • Dual Targeting Strategies in Advanced Non–Small Cell Lung Cancer • Adjuvant Immunotherapy in Non–Small Cell Lung Cancer

Patient Care Perspectives

• Importance of Early Recognition of Actionable Mutations in Non–Small Cell Lung Cancer • Immunotherapy Challenges: Immune-Related Adverse Events and Pseudoprogression • Progression on Targeted Therapy for Non–Small Cell Lung Cancer: Best Practices • Precision Therapies for Non–Small Cell Lung Cancer: Side Effects and Patient Education